Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Flow versus caffeine for apnea of prematurity
2013-005568-24Phase 4Active
- Sponsor
- Medisch Spectrum Twente
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of caffeine in apnea of prematurity (AOP) (3 arms), sponsored by Medisch Spectrum Twente. Primary endpoint: Treatment failure. Started May 2014; status: active.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on 2013-005568-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005568-24.